Valuation (24%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -2.50 | -23.37 |
PEG Ratio (TTM) | 0.76 | -7.10 |
P/S Ratio (TTM) | N/A | 44.34 |
P/B Ratio (TTM) | 1.55 | 33.03 |
P/FCF Ratio (TTM) | -3.21 | -7.73 |
Price to 5YR AVG Earnings Ratio | N/A | -7.08 |
Price to 5YR AVG FCF Ratio | N/A | -13.02 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -49.81% | -15.67% |
ROE (TTM) | -57.66% | 27.44% |
Net Profit Margin (TTM) | N/A | -627.99% |
ROIC 5YR AVG | N/A | -4.84% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -8.43% | -299.01% | N/A |
Revenue | N/A | 19.69% | N/A |
Net Income | -15.05% | -303.84% | N/A |
Cash Flow | -7.62% | -447.52% | N/A |
Health (33%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 5.95 | 5.66 |
Quick Ratio (TTM) | 5.95 | 5.44 |
D/E Ratio (TTM) | N/A | 1.19 |
Interest Coverage (TTM) | -594.64 | -5.92 |
Piotroski F-Score | 3 | 5 |
Altman Z-Score | 0.99 | 13.21 |
LTL to 5YR AVG FCF | N/A | 0.09 |
Shares Outstanding Growth 5YR AVG | N/A | 39.51% |